journal article·2026-08Open access

Sequential release of N-butylphthalide via multifunctional hydrogel for rapid neuroprotection and sustained neural repair after traumatic brain injury

Changbin Hu, Ning Li, Yuanyuan Ran, Hao Fu, Lei Zhou, Fanglei Li, Chenye Qiao, Chuhan Liu, Guiqin Tian, Guoping Guan, Wei Su, Jianing Xi, Zongjian Liu

Abstract

Timely neuroprotective therapy in the acute phase, combined with sustained neural repair strategies in the subacute and chronic phases, is crucial for functional recovery following traumatic brain injury (TBI). However, few pharmaceutical interventions currently achieve cross-phasic modulation with a single administration. Thus, developing a drug delivery system with sequential neuroprotective and neural repair capabilities is urgently required. Herein, we fabricated an injectable multifunctional methacrylated alginate hydrogel integrated with cyclodextrin inclusion complexes (to improve the poor solubility of n-butylphthalide, NBP) and a sucrose acetate isobutyrate (SAIB) depot (to extend retention and enable delayed release). A single implantation of this hydrogel into the post-TBI cavity exerted sequential therapeutic effects: it rapidly released NBP to mitigate ferroptosis in the acute phase, subsequently regulated microglial polarization via sustained release, and ultimately enhanced neural plasticity in the late stages in a mouse model. We employed clinical database analysis, mouse transcriptome analysis, and in vivo experiments, which identified ferroptosis as a key driver of the pathophysiological process of TBI. Further network pharmacology, molecular docking, and in vitro experiments demonstrated that NBP attenuated TBI-induced ferroptosis through the GSK-3β-Fyn-Nrf2 pathway. Collectively, our work provides a multi-stage therapeutic platform with controlled NBP release for TBI intervention.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Neurological Disease Mechanisms and Treatments · Ferroptosis and cancer prognosis · Neuroinflammation and Neurodegeneration Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (65)

Show source-provided references
1. Global burden of traumatic brain and spinal cord injury10.1016/S1474-4422(18)30444-7 ↗
2. Recovery of consciousness and functional outcome in moderate and severe traumatic brain injury10.1001/jamaneurol.2021.0084 ↗
3. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the global burden of disease study 201610.1016/S1474-4422(18)30415-0 ↗
4. Clinical management in traumatic brain injury10.3390/biomedicines12040781 ↗
5. Rethinking neuroprotection in severe traumatic brain injury: toward bedside neuroprotection10.3389/fneur.2017.00354 ↗
6. Microenvironmental variations after blood-brain barrier breakdown in traumatic brain injury10.3389/fnmol.2021.750810 ↗
7. Negative neuroplasticity in chronic traumatic brain injury and implications for neurorehabilitation
8. Traumatic brain injury: mechanisms of glial response10.3389/fphys.2021.740939 ↗
9. Pericontusion axon sprouting is spatially and temporally consistent with a growth-permissive environment after traumatic brain injury10.1097/NEN.0b013e3181cb5bee ↗
10. New insights into the roles of microglial regulation in brain plasticity-dependent stroke recovery10.3389/fncel.2021.727899 ↗
11. Synaptic pathology in traumatic brain injury and therapeutic insights10.3390/ijms26199604 ↗
12. Application and prospects of butylphthalide for the treatment of neurologic diseases10.1097/CM9.0000000000000289 ↗
13. Dl-3-n-butylphthalide exerts neuroprotective effects by modulating hypoxia-inducible factor 1-alpha ubiquitination to attenuate oxidative stress-induced apoptosis10.4103/1673-5374.371366 ↗
14. 3-n-butylphthalide exerts neuroprotective effects by enhancing anti-oxidation and attenuating mitochondrial dysfunction in an in vitro model of ischemic stroke10.2147/DDDT.S189472 ↗
15. DL-3-n-Butylphthalide (NBP) provides neuroprotection in the mice models after traumatic brain injury via Nrf2-ARE signaling pathway10.1007/s11064-017-2186-z ↗
16. Blood-brain barrier pathophysiology in traumatic brain injury10.1007/s12975-011-0125-x ↗
17. Drug delivery challenges in brain disorders across the blood-brain barrier: novel methods and future considerations for improved therapy10.3390/biomedicines9121834 ↗
18. In situ magnetoelectric generation of miRNA sponges and wireless electric stimulus by conductive granular scaffolds for nerve regeneration10.1002/adma.202500650 ↗
19. Wireless in situ catalytic electron signaling-mediated transcriptomic reprogramming for neuron regeneration via adaptable antennas
20. Hydrogel in the treatment of traumatic brain injury10.34133/bmr.0085 ↗
21. Dynamic hydrogel-based strategy for traumatic brain injury modeling and therapy10.1111/cns.70148 ↗
22. Curcumin loaded hydrogel with double ROS-scavenging effect regulates microglia polarization to promote poststroke rehabilitation
23. Multifunctional injectable hydrogel promotes functional recovery after stroke by modulating microglial polarization, angiogenesis and neuroplasticity10.1016/j.cej.2023.142520 ↗
24. Hyaluronan-based hydrogel integrating exosomes for traumatic brain injury repair by promoting angiogenesis and neurogenesis10.1016/j.carbpol.2023.120578 ↗
25. Injectable hyaluronic acid hydrogel loaded with BMSC and NGF for traumatic brain injury treatment
26. In situ implantable and reactive oxygen species responsive hydrogel loaded with minocycline for functional rehabilitation of traumatic brain injury10.1016/j.cej.2025.164322 ↗
27. Serum ferritin correlates with Glasgow coma scale scores and fatal outcome after severe traumatic brain injury10.3109/02699052.2014.995228 ↗
28. Spatial-temporal changes of iron deposition and iron metabolism after traumatic brain injury in mice10.3389/fnmol.2022.949573 ↗
29. Regulation of iron metabolism in ferroptosis: from mechanism research to clinical translation10.1016/j.jpha.2025.101304 ↗
30. NCOA4-Mediated ferritinophagy: a potential link to neurodegeneration10.3389/fnins.2019.00238 ↗
31. The PTBP1-NCOA4 axis promotes ferroptosis in liver cancer cells10.3892/or.2023.8482 ↗
32. Ferroptosis contributes to neuronal death and functional outcome after traumatic brain injury10.1097/CCM.0000000000003555 ↗
33. Gallic acid alleviates ferroptosis by negatively regulating APOC3 and improves nerve function deficit caused by traumatic brain injury10.1038/s41598-025-92383-0 ↗
34. Uncovering the therapeutic efficacy and mechanisms of quercetin on traumatic brain injury animals: a meta-analysis and network pharmacology analysis10.1007/s11011-024-01449-x ↗
35. Targeting Nrf2-Mediated oxidative stress response in traumatic brain injury: therapeutic perspectives of phytochemicals10.1155/2022/1015791 ↗
36. DL-3-n-butylphthalide induced neuroprotection, regenerative repair, functional recovery and psychological benefits following traumatic brain injury in mice10.1016/j.neuint.2017.03.017 ↗
37. Dl-3n-butylphthalide improves traumatic brain injury recovery via inhibiting autophagy-induced blood-brain barrier disruption and cell apoptosis10.1111/jcmm.14691 ↗
38. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 210.1074/jbc.M611336200 ↗
39. Propofol suppresses ferroptosis via modulating eNOS/NO signaling pathway to improve traumatic brain injury10.1002/brb3.70187 ↗
40. FSP1-mediated lipid droplet quality control prevents neutral lipid peroxidation and ferroptosis10.1038/s41556-025-01790-y ↗
41. Neuroprotective effects of pifithrin-α against traumatic brain injury in the striatum through suppression of neuroinflammation, oxidative stress, autophagy, and apoptosis10.1038/s41598-018-19654-x ↗
42. Dl-3-n-butylphthalide inhibits neuroinflammation by stimulating foxp3 and Ki-67 in an ischemic stroke model10.18632/aging.202338 ↗
43. Effects of Dl-3-n-butylphthalide on cerebral ischemia infarction in rat model by mass spectrometry imaging10.3390/ijms18112451 ↗
44. Nanoparticle-based drug delivery for the treatment of traumatic brain injury10.1080/17425247.2023.2152001 ↗
45. In-vivo time course of organ uptake and blood-brain-barrier permeation of poly(L-lactide) and poly(perfluorodecyl acrylate) nanoparticles with different surface properties in unharmed and brain-traumatized rats10.3389/fneur.2023.994877 ↗
46. Mechanisms of blood-brain barrier dysfunction in traumatic brain injury10.3390/ijms21093344 ↗
47. Relevance of half-life in drug design10.1021/acs.jmedchem.7b00969 ↗
48. Understanding drug delivery to the brain using liposome-based strategies: studies that provide mechanistic insights are essential10.1208/s12248-021-00648-z ↗
49. Injectable hydrogels based on hyaluronic acid and gelatin combined with salvianolic acid B and vascular endothelial growth factor for treatment of traumatic brain injury in mice
50. In situ implantable, post-trauma microenvironment-responsive, ROS depletion hydrogels for the treatment of traumatic brain injury10.1016/j.biomaterials.2021.120675 ↗
51. In situ forming and biocompatible hyaluronic acid hydrogel with reactive oxygen species-scavenging activity to improve traumatic brain injury repair by suppressing oxidative stress and neuroinflammation
52. Actuated hydrogel platforms to study brain cell behavior10.1002/adhm.202404484 ↗
53. Traumatic brain injury: bridging pathophysiological insights and precision treatment strategies10.4103/NRR.NRR-D-24-01398 ↗
54. Intranasal delivery systems for traumatic brain injury: advancements and perspectives10.1177/20417314251372373 ↗
55. Remodeling brain pathological microenvironment to lessen cerebral ischemia injury by multifunctional injectable hydrogels10.1016/j.jconrel.2024.03.050 ↗
56. Sustained release of nitric oxide-mediated angiogenesis and nerve repair by mussel-inspired adaptable microreservoirs for brain traumatic injury therapy10.1002/adhm.202470160 ↗
57. Electrosprayed minocycline hydrochloride-loaded microsphere/SAIB hybrid depot for periodontitis treatment10.1080/10717544.2021.1902020 ↗
58. In situ-forming microparticles for controlled release of rivastigmine: in vitro optimization and in vivo evaluation10.3390/ph14010066 ↗
59. Long-term multidomain patterns of change after traumatic brain injury: a TRACK-TBI LONG study10.1212/WNL.0000000000207501 ↗
60. Intermittent theta burst stimulation regulates microglial polarization through Cry1 to enhance neuroplasticity for stroke recovery10.1016/j.expneurol.2025.115255 ↗
61. Melatonin protects against ischemic brain injury by modulating PI3K/AKT signaling pathway via suppression of PTEN activity10.1177/17590914211022888 ↗
62. Baicalein ameliorates ischemic brain damage through suppressing proinflammatory microglia polarization via inhibiting the TLR4/NF-κB and STAT1 pathway10.1016/j.brainres.2021.147626 ↗
63. Microglia in post-traumatic brain injury (TBI) cognitive impairment: from pathological changes to therapeutic approaches10.1111/cns.70568 ↗
64. Microglia in the TBI brain: the good, the bad, and the dysregulated10.1016/j.expneurol.2015.08.018 ↗
65. Traumatic brain injury modifies synaptic plasticity in newly-generated granule cells of the adult hippocampus10.1016/j.expneurol.2020.113527 ↗